Knockdown of LIMD2 inhibits the progression of ovarian carcinoma through ERK1/2 pathway

Publisher Website

Abstract

An abstract is not available for this record. Please visit the publisher website for more details.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now